Background: Radiosurgery has demonstrated good safety and efficacy in the treatment of multiple brain metastases (BMs). However, multi-target dose planning can be challenging and time-consuming. A recently developed real-time inverse treatment planning (IP) by convex optimization has been demonstrated to produce high-quality treatment plans with good conformity and selectivity in single-target plans. We intended to test the capacity of this IP to rapidly generate efficient plans while optimizing the preservation of normal tissue in multiple BM. Methods: Seventy-nine patients (mean age 62.4, age range 22–85) with a total of 272 BMs were treated by Gamma Knife Radiosurgery. All subjects were treated using a forward planning (FP) technique by an expert neurosurgeon. The new Intuitive Plan was applied and able to automatically generate an alternative plan for each patient. All planning variables were collected from the IP to be compared with the corresponding measurements obtained from the FP. A paired sample t test was applied to compare the 2 plans for the following variables: brain volumes receiving 10 Gy (V10) (primary endpoint), and 12 Gy (V12), planning indices (selectivity, coverage, gradient, and Paddick Conformity Index [PCI]), beam-on time (BOT), and integral doses. Additionally, the noninferiority margin for each item was calculated, and the 2 plans were compared for noninferiority using a paired t test. Results: The mean age of patients was 62.4 years old (age range 22–85), with a sex ratio of 1.02. The average number of lesions per patient was 3.4 (range 1–12). The mean prescription dose was 21.46 Gy (range 14–24 Gy). Noninferiority of the IP was concluded for V10, V12, prescription isodose volume, BOT, PCI, and selectivity. The V10 (and V12) was significantly lower with the IP (p < 0.001). These volumes were 8.69 cm3 ± 11.39 and 5.47 cm3 ± 7.03, respectively, for the FP and 7.57 cm3 ± 9.44 and 4.78 cm3 ± 5.86 for the IP. Only the coverage was significantly lower with the IP (−2.3%, p < 0.001), but both selectivity (+17%) and PCI (+15%) were significantly higher with the IP than FP (p < 0.001). Conclusion: This IP demonstrated its capacity to generate multi-target plans rapidly, with a dose to the brain (V10) and BOT noninferior to the one of a human expert planner. These results would benefit from confirmation in a larger prospective series.

1.
Yamamoto
M
,
Serizawa
T
,
Shuto
T
,
Akabane
A
,
Higuchi
Y
,
Kawagishi
J
,
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
.
Lancet Oncol
.
2014
;
15
(
4
):
387
95
. .
2.
Trifiletti
DM
,
Lee
CC
,
Schlesinger
D
,
Larner
JM
,
Xu
Z
,
Sheehan
JP
.
Leukoencephalopathy after stereotactic radiosurgery for brain metastases
.
Int J Radiat Oncol Biol Phys
.
2015
;
93
(
4
):
870
8
. .
3.
Rivers
C
,
Tranquilli
M
,
Prasad
S
,
Winograd
E
,
Plunkett
RJ
,
Fenstermaker
RA
,
Impact of the number of metastatic tumors treated by stereotactic radiosurgery on the dose to normal brain: implications for brain protection
.
Stereotact Funct Neurosurg
.
2017
;
95
(
5
):
352
8
. .
4.
Graber
JJ
,
Cobbs
CS
,
Olson
JJ
.
Congress of neurological surgeons systematic review and evidence-based guidelines on the use of stereotactic radiosurgery in the treatment of adults with metastatic brain tumors
.
Neurosurgery
.
2019 Mar 1
;
84
(
3
):
E168
E70
.
5.
Chin
LS
,
Ma
L
,
DiBiase
S
.
Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up
.
J Neurosurg
.
2001
;
94
(
6
):
899
904
. .
6.
Levivier
M
,
Carrillo
RE
,
Charrier
R
,
Martin
A
,
Thiran
JP
.
A real-time optimal inverse planning for Gamma Knife radiosurgery by convex optimization: description of the system and first dosimetry data
.
J Neurosurg
.
2018
;
129
(
Suppl 1
):
111
7
. .
7.
Régis
J
,
Hamdi
H
,
Loundou
A
,
Merly
L
,
Castillo
L
,
Balossier
A
,
Clinical evaluation of a real-time inverse planning for Gamma Knife radiosurgery by convex optimization: a prospective comparative trial in a series of vestibular schwannoma patients
.
Acta Neurochir
.
2021 Apr
;
163
(
4
):
981
9
.
8.
Gaudy-Marqueste
C
,
Regis
JM
,
Muracciole
X
,
Laurans
R
,
Richard
MA
,
Bonerandi
JJ
,
Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy
.
Int J Radiat Oncol Biol Phys
.
2006
;
65
(
3
):
809
16
. .
9.
Paddick
I
.
A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note
.
J Neurosurg
.
2000
;
93
(
Suppl 3
):
219
22
. .
10.
Korytko
T
,
Radivoyevitch
T
,
Colussi
V
,
Wessels
BW
,
Pillai
K
,
Maciunas
RJ
,
12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors
.
Int J Radiat Oncol Biol Phys
.
2006
;
64
(
2
):
419
24
. .
11.
Voges
J
,
Treuer
H
,
Sturm
V
,
Büchner
C
,
Lehrke
R
,
Kocher
M
,
Risk analysis of linear accelerator radiosurgery
.
Int J Radiat Oncol Biol Phys
.
1996
;
36
(
5
):
1055
63
. .
12.
Paddick
I
,
Lippitz
B
.
A simple dose gradient measurement tool to complement the conformity index
.
J Neurosurg
.
2006
;
105 Suppl
:
194
201
. .
13.
Elliott
AC
,
Woodward
WA
.
Statistical analysis quick reference guidebook: with SPSS examples
.
Sage
;
2007
.
14.
Ghasemi
A
,
Zahediasl
S
.
Normality tests for statistical analysis: a guide for non-statisticians
.
Int J Endocrinol Metab
.
2012
;
10
(
2
):
486
9
. .
15.
Chang
EL
,
Wefel
JS
,
Hess
KR
,
Allen
PK
,
Lang
FF
,
Kornguth
DG
,
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
.
Lancet Oncol
.
2009
;
10
(
11
):
1037
44
. .
16.
Gerard
M
,
Jumeau
R
,
Pichon
B
,
Biau
J
,
Blais
E
,
Horion
J
,
[Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: limits and perspectives]
.
Cancer Radiother
.
2017
;
21
(
6–7
):
636
47
.
17.
Flickinger
JC
,
Kondziolka
D
,
Pollock
BE
,
Maitz
AH
,
Lunsford
LD
.
Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling
.
Int J Radiat Oncol Biol Phys
.
1997
;
38
(
3
):
485
90
. .
18.
Minniti
G
,
Clarke
E
,
Lanzetta
G
,
Osti
MF
,
Trasimeni
G
,
Bozzao
A
,
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
.
Radiat Oncol
.
2011
;
6
:
48
. .
19.
Blonigen
BJ
,
Steinmetz
RD
,
Levin
L
,
Lamba
MA
,
Warnick
RE
,
Breneman
JC
.
Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery
.
Int J Radiat Oncol Biol Phys
.
2010
;
77
(
4
):
996
1001
. .
20.
Ma
L
,
Nichol
A
,
Hossain
S
,
Wang
B
,
Petti
P
,
Vellani
R
,
Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases
.
Int J Comput Assist Radiol Surg
.
2014
;
9
(
6
):
1079
86
. .
21.
Li
XA
,
Soubra
M
,
Szanto
J
,
Gerig
LH
.
Lateral electron equilibrium and electron contamination in measurements of head-scatter factors using miniphantoms and brass caps
.
Med Phys
.
1995
;
22
(
7
):
1167
70
. .
22.
Solberg
TD
,
Medin
PM
.
Quality and safety in stereotactic radiosurgery and stereotactic body radiation therapy: can more be done?
Radiosurg SBRT
.
2011
;
1
(
1
):
13
9
.
23.
Tanny
S
,
Sperling
N
,
Parsai
EI
.
Correction factor measurements for multiple detectors used in small field dosimetry on the Varian Edge radiosurgery system
.
Med Phys
.
2015
;
42
(
9
):
5370
6
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.